Global Health

Vanderbilt University School of Medicine (VUSM), the Vanderbilt Institute for Global Health (VIGH) and the Vanderbilt Eye Institute (VEI) have joined forces with partners in Liberia to strengthen medical education and increase access to ophthalmology care in the aftermath of the 2014-2015 West African Ebola epidemic that killed more than 11,000 people.

New appointments, promotions bolster VUMC's missions.

The Vanderbilt Institute for Global Health (VIGH) has received a five-year, $4.66 million renewal grant from the National Institutes of Health (NIH) to continue a program established in 2012 with Emory, Cornell and Duke universities that is training the next generation of leaders in global health research.

Edwin Trevathan, MD, MPH, a pediatric neurologist and epidemiologist who has previously held prominent university leadership positions at Washington University in St. Louis (director of Pediatric Neurology), St. Louis University (dean, School of Public Health) and Baylor University (Provost and Executive Vice President) as well as at the U.S. Centers for Disease Control and Prevention (CDC), has been appointed director of the Vanderbilt Institute for Global Health (VIGH), effective Jan. 1, 2018.

Kelly McQueen, M.D., MPH, professor of Anesthesiology and Surgery and director of Vanderbilt Anesthesia Global Health and Development, has received the 2017 Nicholas M. Greene, M.D., Outstanding Humanitarian Contribution Award from the American Society of Anesthesiologists (ASA).

Researchers at Vanderbilt University Medical Center are leading an international effort to develop a universal influenza vaccine that would protect everyone against all strains of the flu anywhere in the world.

Researchers in the Vanderbilt Institute for Global Health (VIGH) have received two new grants from the National Institutes of Health (NIH) aimed at reducing the risk of kidney disease in HIV-infected adults and improving the treatment of epilepsy in children in Nigeria.